Development of a high-performance liquid chromatography-tandem mass spectrometry method for the identification and quantification of CP-47,497, CP-47,497-C8 and JWH-250 in mouse brain

Journal of Analytical Toxicology

Volumn 38, Issue 6, 2014, Pages 307-314

  Samano, Kimberly L ^a   Poklis, Justin L ^a   Lichtman, Aron H ^a   Poklis, Alphonse ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 HYDROXY 4 (1,1 DIMETHYLHEPTYL)PHENYL]CYCLOHEXANOL; CANNABINOID DERIVATIVE; CP 47497C8; JWH 250; UNCLASSIFIED DRUG; 1-(1- PENTYL-1H-INDOL-3-YL)-2-(2-METHOXYPHENYL)ETHANONE; 3-(2-HYDROXY-4-(2-METHYLNONAN-2-YL)PHENYL)CYCLOHEXAN-1-OL; ANISOLE DERIVATIVE; CANNABINOID; CP 47497; CYCLOHEXANOL DERIVATIVE; INDOLE DERIVATIVE; PHENOL DERIVATIVE;

ANALYTIC METHOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; BRAIN TISSUE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; MALE; MEASUREMENT ACCURACY; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TEMPERATURE DEPENDENCE; ANIMAL; BRAIN; C57BL MOUSE; CALIBRATION; DEVICES; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIMIT OF DETECTION; METABOLISM; PROCEDURES; REPRODUCIBILITY; STANDARD; SUBSTANCE ABUSE; TISSUE DISTRIBUTION;

ANIMALS; ANISOLES; BEHAVIOR, ANIMAL; BRAIN; CALIBRATION; CANNABINOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANOLS; INDOLES; LIMIT OF DETECTION; MALE; MICE, INBRED C57BL; MICE, INBRED ICR; PHENOLS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

EID: 84904287725     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bku043     Document Type: Article

References (40)

1. 2013) Department of justice schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Federal Register, 78, 17-21.
2. Choi, H., Heo, S., Choe, S., Yang, W., Park, Y., Kim, E. et al. (2013) Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS. Analytical and Bioanalytical Chemistry, 405, 3937-3944.
3. Vardakou, I., Pistos, C., Spiliopoulou, C. (2010) Spice drugs as a new trend: mode of action, identification and legislation. Toxicology Letters, 197, 157-162.
4. Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., Ferreirós, N. (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry, 44, 832-837.
5. Teske, J., Weller, J.-P., Fieguth, A., Rothämel, T., Schulz, Y., Tröger, H.D. (2010) Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, 878, 2659-2663.
6. Weissman, A., Milne, G.M., Melvin, L.S. (1982) Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol. The Journal of Pharmacology and Experimental Therapeutics, 223, 516-523.
7. Haubrich, D.R., Ward, S.J., Baizman, E., Bell, M.R., Bradford, J., Ferrari, R. et al. (1990) Pharmacology of Pravadoline: a new analgesic agent. The Journal of Pharmacology and Experimental Therapeutics, 255, 511-522.
8. Compton, D.R., Gold, L.H., Ward, S.J., Balster, R.L., Martin, B.R. (1992) Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics, 263, 1118-1126.
9. Huffman, J.W., Szklennik, P.V., Almond, A., Bushell, K., Selley, D.E., He, H. et al. (2005) 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorganic & Medicinal Chemistry Letters, 15, 4110-4113.
10. 2009) The drug enforcement administration CP-47,497 seized in Wisconsin. Microgram Bulletin, 42, 89-102.
11. 2013) UNDOC. World Drug Report, 3, 11-14.
12. Zimmermann, U.S., Winkelmann, P.R., Pilhatsch, M., Nees, J.A., Spanagel, R., Schulz, K. (2009) Withdrawal phenomena and dependence syndrome after the consumption of 'spice gold'. Deutsches Arzteblatt International, 106, 464-467.
13. Nacca, N., Vatti, D., Sullivan, R., Sud, P., Su, M., Marraffa, J. (2013) The synthetic cannabinoid withdrawal syndrome. Journal of Addictive Medicine, 7, 296-298.
14. Lindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L. et al. (2009) Spice: a never ending story? Forensic Science International, 191, 58-63.
15. Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P.I. et al. (2010) Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in 'herbal high' products. Journal of Analytical Toxicology, 34, 252-260.
16. Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Haishima, Y., Goda, Y. (2009) Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chemical and Pharmaceutical Bulletin, 57, 439-441.
17. Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., Goda, Y. (2010) Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Science International, 198, 31-38.
18. Hermanns-Clausen, M., Kneisel, S., Szabo, B., Auwärter, V. (2013) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction, 108, 534-544.
19. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2009) Thematic paper-Understanding the 'Spice' phenomenon. http://www.emcdda.europa.eu/publications/thematicpapers/spice, 1-34.
20. Huffman, J.W., Thompson, A.L.S., Wiley, J.L., Martin, B.R. (2008) Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940. Bioorganic Medicinal Chemistry, 16, 322-335.
21. Atwood, B.K., Lee, D., Straiker, A., Widlanski, T.S., Mackie, K. (2011) CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB1 cannabinoid receptor agonists. European Journal of Pharmacology, 659, 139-145.
22. Melvin, L.S., Milne, G.M., Johnson, M.R., Subramaniam, B., Wilken, G.H., Howlett, A.C. (1993) Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. Molecular Pharmacology, 44, 1006-1015.
23. Wiebelhaus, J.M., Poklis, J.L., Poklis, A., Vann, R.E., Lichtman, A.H., Wise, L.E. (2012) Inhalation exposure to smoke from synthetic 'marijuana' produces potent cannabimimetic effects in mice. Drug Alcohol Dependence, 126, 316-323.
24. Poklis, J.L., Amira, D., Wise, L.E., Wiebelhaus, J.M., Haggerty, B.J., Poklis, A. (2012) Detection and disposition of JWH-018 and JWH-073 in mice after exposure to 'Magic Gold' smoke. Forensic Science International, 220, 91-96.
25. Poklis, J.L., Amira, D., Wise, L.E., Wiebelhaus, J.M., Haggerty, B.J., Lichtlman, A.H. et al. (2012) Determination of naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in mouse blood and tissue after inhalation exposure to 'buzz' smoke by HPLC/MS/MS. Biomedicinal Chromatography: BMC, 26, 1393-1398.
26. Mura, P., Kintz, P., Dumestre, V., Raul, S., Hauet, T. (2005) THC can be detected in brain while absent in blood. Journal of Analytical Toxicology, 29, 842-843.
27. Samano, K.S., Ignatowska-Jankowska, B.M., Lichtman, A.H., Poklis, A. (2013) Preclinical Investigation of CP47,497: a widely abused synthetic cannabinoid. Abstract #K24, American Academy of Forensic Science 65th Annual Meeting, February 18-23, Washington, D.C.
28. Wiley, J. (2003) Cannabinoid pharmacological properties common to other centrally acting drugs. European Journal of Pharmacology, 471, 185-193.
29. Martin, B.R., Compton, D.R., Thomas, B.F., Prescott, W.R., Little, P.J., Razdan, R.K. et al. (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacology, Biochemistry and Behavior, 40, 471-478.
30. Foltz, R.L., McGinnis, K.M., Chinn, D.M. (1983) Quantitative measurement of delta 9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry. Biomedical Mass Spectrometry, 10, 316-323.
31. Poklis, J.L., Thompson, C.C., Long, K.A., Lichtman, A.H., Poklis, A. (2010) Disposition of cannabichromene, cannabidiol, and D9-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 34, 516-520.
32. 2013) Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology report. Journal of Analytical Toxicology, 37, 452-474.
33. US Department of Health and Human Services. (2001) Bioanalytical method validation: a guidance for industry. US Department of Health and Human Services, 7-8.
34. Haggerty, B.J., Poklis, J.L., Wolf, C.E., Wise, L.E., Wiebelhaus, J.M., Lichtman, A.H., Poklis, A. (2010) Detection of cannabimimetic compounds in mice blood after exposure to Buzz smoke. Abstract. Society of Forensic Toxicologists 40th Annual Meeting, October 19-22, Richmond, VA.
35. Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., Auwärter, V. (2011) Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46, 163-171.
36. Kacinko, S.L., Xu, A., Homan, J.W., McMullin, M.M., Warrington, D.M., Logan, B.K. (2011) Development and validation of a liquid chromatography-tandem mass spectrometry method for the Identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood. Journal of Analytical Toxicology, 35, 386-393.
37. Ammann, J., McLaren, J.M., Gerostamoulos, D., Beyer, J. (2012) Detection and quantification of new designer drugs in human blood: part 1-synthetic cannabinoids. Journal of Analytical Toxicology, 36, 372-380.
38. Compton, D.R., Rice, K.C., De Costa, B.R., Razdan, R.K., Melvin, L.S., Johnson, M.R. et al. (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. 265, 218-226.
39. Wiley, J.L., Marusich, J.A., Martin, B.R., Huffman, J.W. (2012) 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice. Drug Alcohol Dependence, 123, 148-153.
40. Yeakel, J.K., Logan, B.K. (2013) Blood synthetic cannabinoid concentrations in cases of suspected impaired driving. Journal of Analytical Toxicology, 37, 547-551.